Curetis sets up new cartridge manufacturing facility.
The supervisory board of Curetis AG has appointed Oliver Schacht to join the company full time as its CEO.
Curetis appoints Oliver Schacht as CEO
Subscribe to Curetis Newsletter
Curetis To Attend Key Investor and Scientific Conferences In The Third Quarter 2018
Curetis Launches Unyvero System and LRT Cartridge for Lower Respiratory Tract Infections in the U.S.
ASM - Microbe 2018 - Alanta, USA - June 8 to 10, 2018
19 Journées Nationales d’Infectiologie, Nantes, France - June 13 to 15, 2018